Stock, pipeline and biotech catalyst intelligence
Clinical portfolio
The page remains usable with the verified company and catalyst data already on file.
Upcoming milestones
The page remains usable with the verified company and catalyst data already on file.
Company profile
Under normal market circumstances, the fund will maintain at least 80% exposure to financial instruments that provide two times leveraged exposure to the daily performance of SNPS. This may include SNPS stock in addition to financial instruments. The fund is non-diversified.
Company profile supplied by Yahoo Finance. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Apr 20, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.